Brief: Kedrion Announces Eight-Year Extension Of Distribution Agreement With Kamada In US For Kedrab
07/12/2023 16:06
Dec 7 (Reuters) - Kedrion Biopharma:
* KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE
DISTRIBUTION
AGREEMENT WITH KAMADA IN THE US FOR KEDRAB
* KEDRION BIOPHARMA- NEW AGREEMENT WITH KAMADA BECOMES
EFFECTIVE
IN JANUARY 2024
* KEDRION BIOPHARMA- CO, KAMADA WILL COLLABORATE TO EXPAND
DISTRIBUTION OF KEDRION PRODUCTS BY KAMADA IN ISRAEL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kamada
See all newsBrief: Kamada Updates On Withholding Tax Procedures On Previously Announced Cash Dividend To Shareholders
Brief: Kamada Announces Planned Transition Of Chief Financial Officer
Brief: Kamada Q2 EPS USD 0.16
Brief: Kamada Announces FDA Approval Of Its New In-House Rabies Virus Neutralization Testing Laboratory
Brief: Kamada Q4 EPS USD 0.06